Vaxxinity’s beta-amyloid vaccine to treat Alzheimer’s disease — UB-311 — recently received fast track designation as it finishes up Phase 2 trials. Image: Vaxxinity…
The Food and Drug Administration issued an update to Aduhelm’s label, now requiring a total of four MRIs during the first year of treatment…
Biogen has withdrawn the application anti-amyloid Alzheimer’s drug Aduhelm from Europe’s regulatory agency. Biogen has abandoned its application for the approval of anti-amyloid Alzheimer’s…
Scientists are exploring the role of tau tangles in Alzheimer’s, and whether addressing these misfolded proteins could treat the disease. Here’s what you need…
Brain cells called oligodendrocytes wrap protective sheaths around neurons. But when that protection starts to break down, it may distract the brain’s cleaning crew,…
Scientists are studying brain cells called microglia to better understand the causes of Alzheimer’s — as well as new avenues for treatment. Imagine the…
Neurobiologist Karl Herrup shares his take on why the field of Alzheimer’s has struggled to find a cure, and what it would take to…